Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A registrational trial of RP-L102 for Fanconi's Anemia

Trial Profile

A registrational trial of RP-L102 for Fanconi's Anemia

Phase of Trial: Phase III

Latest Information Update: 24 May 2018

At a glance

  • Drugs RP L102 (Primary)
  • Indications Fanconi's anaemia
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 24 May 2018 New trial record
    • 17 May 2018 According to a Rocket Pharmaceuticals media release, this trial is expected to be initiated in 2019. This trial is supported by the Stanford University School of Medicine under an agreement with the company.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top